Coalition to Heal Invisible Wounds
Advocacy for improved support of research and development for PTSD & TBI medical therapies
Based in DC
🤖
AI Overview
With $1.0M in lobbying spend across 29 quarterly filings, Coalition to Heal Invisible Wounds is a significant lobbying presence. Their lobbying covers 3 issue areas. Active from 2018 to 2025.
$1.0M
Total Spend
8
Years Active
1
Firms Hired
7
Lobbyists Deployed
3
Issues Lobbied
Spending Trend
View as table
| Year | Lobbying Spend |
|---|---|
| 2018 | $240K |
| 2019 | $210K |
| 2020 | $200K |
| 2021 | $120K |
| 2022 | $120K |
| 2023 | $120K |
| 2024 | $30K |
| 2025 | $0 |
Issues Lobbied
Lobbying Firms
Lobbyists
What They Lobby About
These are actual descriptions from their quarterly lobbying disclosure filings, summarizing what they lobbied Congress and federal agencies about.Issue areas: Veterans, Defense, Health Issues
- •Enhancing VA and DOD support for clinical research and development of new treatments.
Related Analysis
Related Investigations
The Defense Lobby
Defense contractors spend millions lobbying for contracts worth billions.
Lobbying vs. Federal Contracts
How lobbying spending correlates with contract awards.
Big Pharma's $452M Lobbying Machine
How pharmaceutical companies spend hundreds of millions to influence health policy.
Healthcare's $3 Billion Bet
The healthcare industry's massive lobbying investment.
Federal Lobbying Statistics 2025
The definitive stats — $37.7B total, industry breakdowns, and trends.
What Is Lobbying? A Complete Guide
How lobbying works, who does it, and why it matters.
Similar Clients
American Psychological Association Services Inc.(fka American Psychological Assn
$10.9M total spend
American College of Obstetricians and Gynecologists
$8.9M total spend
Giffords
$4.5M total spend
American Society for Reproductive Medicine
$190K total spend
Cassidy & Associates on Behalf of Cerner Corporation
$180K total spend
Explore More
Data Sources: Senate LDA Filings
Last updated: February 2026
This site is an independent journalism project. Analysis and editorial content are not affiliated with or endorsed by any government agency.